Is Goldman Sachs Stock a Buy Sell or Hold?
When the Federal Reserve started hiking rates in 2022, banks’…
Sell
24
AEMD Quote, Financials, Valuation and Earnings
Last price:
$0.38
Seasonality move
:
-13.22%
Day range:
$0.37 - $0.43
52-week range:
$0.24 - $1.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.25x
Volume:
276.1K
Avg. volume:
377.3K
1-year change:
-77.89%
Market cap:
$5.4M
Revenue:
$574.3K
EPS (TTM):
-$1.58
Analysts' Opinion
-
Consensus RatingAethlon Medical has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $3.88, Aethlon Medical has an estimated upside of 936.96% from its current price of $0.37.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $0.75 representing 100% downside risk from its current price of $0.37.
Fair Value
-
According to the consensus of 1 analyst, Aethlon Medical has 936.96% upside to fair value with a price target of $3.88 per share.
AEMD vs. S&P 500
-
Over the past 5 trading days, Aethlon Medical has underperformed the S&P 500 by -12.42% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Aethlon Medical does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Aethlon Medical has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Aethlon Medical reported revenues of --.
Earnings Growth
-
Aethlon Medical has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Aethlon Medical reported earnings per share of -$0.13.
Enterprise value:
577.1K
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.07x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$13.2M | -$12.6M | -$9.8M | -$3.6M | -$1.8M | |
| EBITDA | -$13M | -$12.3M | -$9.5M | -$3.5M | -$1.7M | |
| Diluted EPS | -$7.48 | -$4.96 | -$1.58 | -$1.37 | -$0.13 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $12.3M | $21.2M | $18.2M | $8.2M | $5M | |
| Total Assets | $12.7M | $21.9M | $20.7M | $10.4M | $6.5M | |
| Current Liabilities | $1.2M | $1.1M | $2.4M | $2.1M | $1.8M | |
| Total Liabilities | $1.2M | $1.4M | $3.4M | $2.8M | $2.2M | |
| Total Equity | $11.4M | $20.6M | $17.3M | $7.6M | $4.3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$10.7M | -$10.5M | -$8.5M | -$2.4M | -$2M | |
| Cash From Investing | -$1.1M | -$257.2K | -$7.1K | -$8.8K | -$2.2K | |
| Cash From Financing | $8.9M | $1.2M | $5.4M | $177.1K | -$7.1K | |
| Free Cash Flow | -$11.8M | -$10.8M | -$8.5M | -$2.4M | -$2M | |
AEMD
Sector
Market Cap
$5.4M
$38.4M
Price % of 52-Week High
20.2%
45.53%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.78%
1-Year Price Total Return
-77.89%
-39.05%
Beta (5-Year)
1.804
0.774
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$0.44
200-day SMA
Sell
Level
$0.48
Bollinger Bands (100)
Sell
Level
0.37 - 0.67
Chaikin Money Flow
Sell
Level
-482.4M
20-day SMA
Sell
Level
$0.52
Relative Strength Index (RSI14)
Sell
Level
30.40
ADX Line
Sell
Level
28.98
Williams %R
Buy
Level
-99.6947
50-day SMA
Sell
Level
$0.63
MACD (12, 26)
Sell
Level
-0.06
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Neutral
Level
1.2B
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-10.5032)
Sell
CA Score
(Annual)
Level (-1.6513)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (9.3498)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
Stock Forecast FAQ
In the current month, AEMD has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The AEMD average analyst price target in the past 3 months is $3.88.
-
Where Will Aethlon Medical Stock Be In 1 Year?
According to analysts, the consensus estimate is that Aethlon Medical share price will rise to $3.88 per share over the next 12 months.
-
What Do Analysts Say About Aethlon Medical?
Analysts are divided on their view about Aethlon Medical share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Aethlon Medical is a Sell and believe this share price will drop from its current level to $0.75.
-
What Is Aethlon Medical's Price Target?
The price target for Aethlon Medical over the next 1-year time period is forecast to be $3.88 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is AEMD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Aethlon Medical is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of AEMD?
You can purchase shares of Aethlon Medical via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Aethlon Medical shares.
-
What Is The Aethlon Medical Share Price Today?
Aethlon Medical was last trading at $0.38 per share. This represents the most recent stock quote for Aethlon Medical. Yesterday, Aethlon Medical closed at $0.37 per share.
-
How To Buy Aethlon Medical Stock Online?
In order to purchase Aethlon Medical stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Reddit a Buy on the Dip?
Reddit (NYSE:RDDT) share price has been on the proverbial ropes…
Qualcomm Stock: 5G Leader at a Bargain Price?
Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
59
GRRR alert for Mar 15
Gorilla Technology Group [GRRR] is up 29.72% over the past day.
Sell
49
SMTC alert for Mar 15
Semtech [SMTC] is up 21.28% over the past day.
Buy
62
PLPC alert for Mar 15
Preformed Line Products [PLPC] is up 17.38% over the past day.
